Announcement

Collapse
No announcement yet.

US - CDC: COVID Data Tracker Weekly Review 2021 - 2024 - For trend analysis only

Collapse
This is a sticky topic.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #76

    Print
    Subscribe to the Weekly Review

    Interpretive Summary for February 3, 2023
    Variant Roundup


    The virus that causes COVID-19 is constantly changing. We continue to see new lineages of the Omicron variant, such as XBB.1.5, emerge and spread in the United States. This week, we provide an update on the most common Omicron lineages currently circulating in the United States.
    • XBB.1.5 is a sublineage of the XBB lineage, which is a combination of two earlier Omicron lineages: BM.1.1 and BJ. As Nowcast projected, XBB.1.5 has risen to be the predominant Omicron lineage in the United States, accounting for an estimated 66.4% of all new cases. It is the only major lineage currently increasing in proportion in the country. Learn more about XBB.1.5 in A Closer Look below.
    • BQ.1 and BQ.1.1 are sublineages of the BA.5 lineage of the Omicron variant. BA.5 and its sublineages are continuing to decrease in proportion nationally. According to Nowcast projections, BQ.1 and BQ.1.1 together represent about 27% of all weekly cases.
    • CH.1.1 is a sublineage of BA.2.75. CH.1.1 is predicted to make up an estimated 1.6% of circulating viruses nationally, according to Nowcast projections. These percentages represent a steady decline.

    CDC will continue to watch the Omicron variant and its lineages closely and monitor how well vaccines and other treatments perform. On January 26, the U.S. Food and Drug Administration announced that Evusheld is no longer authorized for emergency use in the United States. Data show that Evusheld is unlikely to be active against certain SARS-CoV-2 lineages, including the main lineages circulating now. It is important that people who are moderately to severely immunocompromised exercise caution and recognize the need for additional prevention measures, as well as other treatment options.

    COVID-19 vaccines are an effective way to protect yourself against severe COVID-19. The updated booster vaccine has been reformulated to better protect against the most recently circulating variants. It can also help restore protection that has waned since previous vaccination. Unfortunately, uptake is at an all-time low since vaccines were rolled out in early 2021—only about one in six people in the United States (15.7%) have received an updated COVID-19 booster. CDC recommends that everyone ages 5 years and older get an updated booster if it has been at least two months since their last COVID-19 dose (either primary series or original booster). Children ages 6 months through 5 years who completed the Moderna COVID-19 vaccine primary series can also get an updated COVID-19 booster. Find a vaccine.

    Note to Readers: To help people visualize how variants emerge, disappear, and persist, CDC’s COVID Data Tracker added a dendrogram (tree diagram) to the Summary of Variant Surveillance and Variant Proportions pages. Dendrograms are like variant family trees, showing the genetic relationships between the lineages displayed on the COVID Data Tracker genomic surveillance pages.


    What's New
    COVID-19 Community Levels*


    As of February 2, 2023, there are 130 (4%) counties, districts, or territories with a high COVID-19 Community Level, 818 (25.4%) with a medium Community Level, and 2,269 (70.5%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level increased by 0.4%, in the medium level decreased by 1.1%, and in the low level increased by 0.8%. Overall, 47 out of 52 jurisdictions** had high- or medium-level counties this week. Arizona, District of Columbia, Hawaii, Nevada, and Utah are the only jurisdictions to have all counties at low Community Levels.

    To check your COVID-19 Community Level, visit COVID Data Tracker. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

    *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transition Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

    **Includes the 50 states, the District of Columbia, and Puerto Rico.

    U.S. COVID-19 Community Levels by County


    View Larger
    COVID-19 Community Levels
    Reported Cases


    As of February 1, 2023, the current 7-day average of weekly new cases (40,130) decreased 6.7% compared with the previous 7-day average (43,035). A total of 102,447,438 COVID-19 cases have been reported in the United States as of February 1, 2023.

    102,447,438
    Total Cases Reported

    40,130
    Current 7-Day Average*

    43,035
    Previous 7-Day Average

    -6.7%
    Change in 7-Day Average since Previous Period

    *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 25,904 historical cases reported retroactively, 4,507 were reported in the current week and none in the prior week.

    Weekly Trends in COVID-19 Cases in the United States Reported to CDC


    View Larger
    More Case DataCOVID-19 Variants


    CDC Nowcast projections* for the week ending February 4, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, BQ.1.1, BQ.1, XBB, CH.1.1, and BN.1.

    XBB.1.5 is projected to be at approximately 66.4% (95% PI 59.8-72.5%). The second most prevalent lineage is BQ.1.1, projected to be at approximately 19.9% (95% PI 16.2-24.1%).

    BQ.1, XBB, CH.1.1, and BN.1 are all projected to be between 1% and 8% of circulating lineages.

    XBB.1.5 is growing in proportion in all HHS regions. All other virus lineages are predicted to have very slow or no growth in proportion.

    See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

    *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.


    View Larger
    Vaccinations


    As of February 1, 2023, 669.6 million vaccine doses have been administered in the United States. Overall, about 229.7 million people, or 69.2% of the total U.S. population, have completed a primary series.* More than 42.1 million people, or 20.1% of the eligible U.S. population ages 5 years and older, have received an updated booster dose.

    669,600,840
    Vaccine Doses Administered

    52,357,882
    Updated Booster Doses Administered**

    229,719,115
    People who have completed a primary series* (69.2% of the U.S. population)

    42,131,004
    People who have received an updated booster (20.1% of the eligible U.S. population)***

    +0.0
    Percentage point change from last week

    +0.2
    Percentage point change from last week

    *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

    **Includes all updated booster doses administered regardless of recipient eligibility.

    ***Includes only recipients who are eligible to receive an updated booster. Beginning January 20, 2023, the “People who have received an updated booster” count was revised from including all people who received an updated booster to only eligible people who received an updated booster.

    Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

    7-Day moving average


    View Larger
    COVID-19 Updated Booster Dose Administration, United States


    View Larger
    More Vaccination Data
    Hospitalizations

    New Hospital Admissions


    The current 7-day daily average for January 25–31, 2023, was 3,919. This is an 8.4% decrease from the prior 7-day average (4,279) from January 18–24, 2023.

    5,897,893
    Total New Admissions

    3,919
    Current 7-Day Average

    4,279
    Prior 7-Day Average

    -8.4%
    Change in 7-Day Average

    The start of consistent reporting of hospital admissions data was August 1, 2020.

    Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


    View Larger
    New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

    More Hospital Data
    RESP-NET: COVID-19 Associated Hospitalization Rates among Adults Ages 65 Years and Older


    CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) shows that overall weekly rates of COVID-19-associated hospitalizations appear to be beginning to decrease from a peak in December 2022. However, overall COVID-19-associated hospitalization rates remain elevated, at 8.2 per 100,000 population for the week ending January 14, 2023.

    Weekly Rates of Respiratory Virus-Associated Hospitalizations among Adults Ages 65 Years and Older


    View Larger
    The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

    More COVID-NET Data
    Deaths


    The current 7-day average of new deaths (493) decreased 9.0% compared with the previous 7-day average (542). As of February 1, 2023, a total of 1,106,824 COVID-19 deaths have been reported in the United States.

    1,106,824
    Total Deaths Reported

    493
    Current 7-Day Average*

    542
    Prior 7-Day Average

    9.0%
    Change in 7-Day Average Since Prior Period

    *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 3,838 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

    Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


    View Larger
    More Death Data
    Testing


    The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is increasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 11.0%. The 7-day average number of tests reported for January 20–26, 2023, was 273,284, down 13.1% from 314,594 for the prior 7 days.

    1,012,215,832
    Total Tests Reported

    273,284
    7-Day Average Tests Reported

    11.0%
    7-Day Average % Positivity

    10.5%
    Previous 7-Day Average % Positivity

    0.55
    Percentage point change in 7-Day Average % Positivity since Prior Week

    *Test for SARS-CoV-2, the virus that causes COVID-19

    COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


    View Larger
    More Testing DataWastewater Surveillance


    COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,100 testing sites across the country.

    Currently, about 62% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 28% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 45% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 44% are reporting an increase.

    For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

    *The virus that causes COVID-19

    SARS-CoV-2 Levels in Wastewater by Site


    View Larger


    0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

    More Wastewater Data

    A Closer Look

    Learn More about XBB.1.5

    XBB.1.5, a lineage of the Omicron variant, has recently become the predominant lineage circulating in the United States, with a projected prevalence of 66.4% for the week ending February 4, 2022. It was first detected in the United States in October 2022. XBB.1.5 is the only major lineage currently increasing in proportion across the country, and it is expected to continue increasing in all U.S. regions. It is most prevalent in the Northeastern states, where the proportions are estimated to be greater than 90%. XBB.1.5 is less common in other countries but has been detected in Europe, Asia, South America, and Africa.

    XBB.1.5 became the dominant lineage fairly quickly. It has two additional spike substitutions (G252V and S486P), which may contribute to its apparent increased transmissibility. The severity of XBB.1.5 has not been fully assessed, but there is no indication right now that it causes more serious illness than other Omicron lineages.

    Preliminary data from CDC and other researchers suggest that updated booster vaccine protection is similar against XBB.1.5 and other recent Omicron lineages. A recent CDC study shows that the updated COVID-19 boosters add protection against illness with Omicron XBB/XBB.1.5-related variants for at least the first three months after vaccination.

    Antiviral treatments, such as Paxlovid and Veklury (remdesivir), are expected to be effective against XBB.1.5 and other Omicron lineages. But laboratory data has shown that pre-exposure drug Evusheld is not effective against the lineages (including XBB.1.5) that are currently causing more than 90% of the cases in the United States. As a result, on January 26, 2023, the U.S. Food and Drug Administration announced that Evusheld is no longer authorized for use in the United States until further notice.

    CDC will continue to watch XBB.1.5 and monitor how well vaccines and other treatments perform against this new variant. It is likely that XBB.1.5 will continue to spread. Those who are up to date on their COVID-19 vaccinations have the most protection to fight off an infection caused by XBB.1.5. Most people will have minor or even potentially no symptoms and will not need to go to the hospital. However, people who are at higher risk for severe disease should continue to take precautions to protect themselves. Anyone who has symptoms or an exposure to COVID-19 should get tested. If they test positive, they should talk to their doctor or healthcare provider about treatments that may be right for them. This assessment could change as more data are available.

    Comment


    • #77


      Print
      Subscribe to the Weekly Review

      Interpretive Summary for February 10, 2023
      Create a COVID-19 Action Plan


      Since the beginning of the COVID-19 pandemic almost three years ago, we have known that some people who are immunocompromised (have a weakened immune system) are more likely to get sick with COVID-19 or be sick for a longer period. Evusheld, a pre-exposure preventative treatment, gave people with weakened immune systems extra protection against severe outcomes from COVID-19. However, on January 26, 2023, the U.S. Food and Drug Administration announced that Evusheld is not currently authorized for emergency use in the United States because it is unlikely to be active against the majority of circulating SARS-CoV-2 variants at this time.

      With this change, CDC encourages people who have weakened immune systems (or who live with someone who does) to create a COVID-19 action plan (en español). Vaccination is the first line of protection to prevent serious illness, hospitalization, and death from COVID-19. People who are immunocompromised might not have as strong of an immune response to COVID-19 vaccines, but staying up to date with COVID-19 vaccines will help. Everyone who is eligible should stay up to date with COVID-19 vaccines and boosters for the added protection.

      If you have a weakened immune system and test positive for SARS-COV-2 or have a known exposure, talk to a doctor to get antiviral treatment as soon as possible. You should also consider prevention measures such as wearing a comfortable, well-fitting respirator or mask, maintaining physical distance (more than 6 feet) from others, improving indoor ventilation, and washing your hands often. CDC’s People Who Are Immunocompromised and Steps for People with Weakened Immune Systems to Stay Safe from COVID-19 pages have more information on how to protect yourself from COVID-19.

      Note to Readers: CDC will not publish the COVID Data Tracker Weekly Review on Friday, February 17, 2023. Publication will resume on Friday, February 24, 2023.


      What's New
      COVID-19 Community Levels*


      As of February 9, 2023, there are 91 (2.8%) counties, districts, or territories with a high COVID-19 Community Level, 715 (22.2%) with a medium Community Level, and 2,407 (74.8%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level decreased by 1.2%, in the medium level decreased by 3.2%, and in the low level increased by 4.3%. Overall, 47 out of 52 jurisdictions** had high- or medium-level counties this week. Arizona, District of Columbia, Hawaii, New Hampshire, and Utah are the only jurisdictions to have all counties at low Community Levels.

      To check your COVID-19 Community Level, visit . To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

      *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

      **Includes the 50 states, the District of Columbia, and Puerto Rico.

      U.S. COVID-19 Community Levels by County


      View Larger
      COVID-19 Community Levels
      Reported Cases


      As of February 8, 2023, the current 7-day average of weekly new cases (40,404) decreased 1.0% compared with the previous 7-day average (40,815). A total of 102,736,819 COVID-19 cases have been reported in the United States as of February 8, 2023.

      102,736,819
      Total Cases Reported

      40,404
      Current 7-Day Average*

      40,815
      Previous 7-Day Average

      -1.0%
      Change in 7-Day Average since Previous Period

      *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 25,904 historical cases reported retroactively, 4,507 were reported in the current week and none in the prior week.

      Weekly Trends in COVID-19 Cases in the United States Reported to CDC


      View Larger
      More Case DataCOVID-19 Variants


      CDC Nowcast projections* for the week ending February 11, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, BQ.1.1, BQ.1, XBB, and CH.1.1.

      XBB.1.5 is projected to be at approximately 74.7% (95% PI 67.0-81.2%). XBB.1.5 is expected to have at least one sublineage (XBB.1.5.1) that may be broken out by CDT next week, when it is expected to be above 1% weighted estimates.

      The second most prevalent lineage is BQ.1.1, projected to be at approximately 15.3% (95% PI 11.4-20.2%).

      BQ.1, XBB, CH.1.1, and BN.1 are all projected to be between 1% and 5.1% of circulating lineages.

      XBB.1.5 is growing in proportion in all HHS regions. All other virus lineages are predicted to have very slow or no growth in proportion.

      See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

      *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.


      View Larger
      Vaccinations


      As of February 8, 2023, 670.3 million vaccine doses have been administered in the United States. Overall, about 229.8 million people, or 69.2% of the total U.S. population, have completed a primary series.* About 52.5 million people, or 15.8% of the U.S. population, have received an updated booster dose.

      670,306,507
      Vaccine Doses Administered

      52,871,702
      Updated Booster Doses Administered**

      229,820,324
      People who have completed a primary series* (69.2% of the U.S. population)

      52,499,720
      People who have received an updated booster (15.8% of the eligible U.S. population)

      +0.0
      Percentage point change from last week

      +0.1
      Percentage point change from last week

      *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

      **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

      Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

      7-Day moving average


      View Larger
      COVID-19 Updated Booster Dose Administration, United States


      View Larger
      More Vaccination Data
      Hospitalizations

      New Hospital Admissions


      The current 7-day daily average for February 1–7, 2023, was 3,665. This is an 6.2% decrease from the prior 7-day average (3,907) from January 25–31, 2023.

      5,924,203
      Total New Admissions

      3,665
      Current 7-Day Average

      3,907
      Prior 7-Day Average

      -6.2%
      Change in 7-Day Average

      The start of consistent reporting of hospital admissions data was August 1, 2020.

      Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


      View Larger
      New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

      More Hospital Data
      RESP-NET: COVID-19 Associated Hospitalization Rates among Adults Ages 65 Years and Older


      CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) shows that overall weekly rates of COVID-19-associated hospitalizations have declined for all age groups from a peak in December 2022. However, adults ages 65 years and older continue to be disproportionately impacted by COVID-19 associated hospitalizations, accounting for nearly half of all cases since October 1, 2022, with a weekly rate of 27.4 per 100,000 population for the week ending January 21, 2023.

      Weekly Rates of Respiratory Virus-Associated Hospitalizations among Adults Ages 65 Years and Older


      View Larger


      The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

      More COVID-NET Data
      Deaths


      The current 7-day average of new deaths (453) decreased 9.7% compared with the previous 7-day average (502). As of February 8, 2023, a total of 1,110,364 COVID-19 deaths have been reported in the United States.

      1,110,364
      Total Deaths Reported

      453
      Current 7-Day Average*

      502
      Prior 7-Day Average

      -9.7%
      Change in 7-Day Average Since Prior Period

      *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 3,838 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

      Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


      View Larger
      More Death Data
      Testing


      The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is increasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 10.6%. The 7-day average number of tests reported for January 27–February 2, 2023, was 257,631, down 17.7% from 313,044 for the prior 7 days.

      1,014,370,606
      Total Tests Reported

      257,631
      7-Day Average Tests Reported

      10.6%
      7-Day Average % Positivity

      10.2%
      Previous 7-Day Average % Positivity

      +0.44
      Percentage point change in 7-Day Average % Positivity since Prior Week

      *Test for SARS-CoV-2, the virus that causes COVID-19

      COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


      View Larger
      More Testing DataWastewater Surveillance


      COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,200 testing sites across the country.

      Currently, about 65% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 29% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 41% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 49% are reporting an increase.

      For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

      *The virus that causes COVID-19

      SARS-CoV-2 Levels in Wastewater by Site


      View Larger


      0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

      Comment


      • #78


        Print
        Subscribe to the Weekly Review

        Interpretive Summary for February 24, 2023
        Evolution of Pandemic Efforts


        A few weeks ago, the federal government announced plans to end the COVID-19 Public Health Emergency (PHE) on May 11, 2023. COVID-19 remains a public health priority—it has impacted all aspects of daily life and contributed to a decline in life expectancy. Many people remain at higher risk for severe illness and death. However, we are in a much better place than we were three years ago. Widespread prevention and control measures like vaccination are helping transition to a new era in the pandemic. This is the first in a series of Weekly Review discussions about the end of the PHE and what it means for CDC and the data we report.

        The end of the PHE doesn’t mean that CDC will stop tracking COVID-19 and sharing information and data. Most CDC COVID-19 data activities won’t be directly affected, but there will be changes. For example, some hospitalization data are now reported daily but may be reported less frequently in the future, and vaccine administration data might be reduced in some areas. To ensure the public continues to have access to COVID-19 data, CDC is working to determine which data products remain critical for monitoring public health, preparedness, and patient safety.

        CDC remains dedicated to preventing severe illness and death from COVID-19, with particular concern for people who are at higher risk. COVID-19 remains a critical public health issue, still the sixth leading cause of death in the United States in January 2023. CDC is actively working with other federal government agencies and offices to maintain as much access as possible to vaccines, testing, and treatments. It remains important to stay up to date with COVID-19 vaccines, especially for people at higher risk for severe disease. Find a vaccine.

        Note to Readers: The Disability Information and Access Line can help people with disabilities find local vaccination locations, make appointments, find accessible transportation options, and connect with other community resources to improve access to vaccinations.

        Note to Readers: COVID Data Tracker Weekly Review will publish every other week starting March 3, 2023. Please visit CDC’s COVID Data Tracker for COVID-19 data, CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for data on respiratory virus-associated hospitalizations, and CDC’s National Emergency Department Visits for COVID-19, Influenza, and Respiratory Syncytial Virus dashboard for data on emergency department patient visits with diagnosed COVID-19, influenza, and RSV.


        What's New
        COVID-19 Community Levels*


        As of February 23, 2023, there are 67 (2.1%) counties, districts, or territories with a high COVID-19 Community Level, 655 (20.3%) with a medium Community Level, and 2,498 (77.6%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level decreased by 0.5%, in the medium level increased by 0.2%, and in the low level increased by 0.3%. Overall, 44 out of 52 jurisdictions** had high- or medium-level counties this week. District of Columbia, Nevada, New Mexico, Puerto Rico, Rhode Island, South Carolina, Utah and Washington are the only jurisdictions to have all counties at low Community Levels.

        To check your COVID-19 Community Level, visit . To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

        *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

        **Includes the 50 states, the District of Columbia, and Puerto Rico.

        U.S. COVID-19 Community Levels by County


        View Larger
        COVID-19 Community Levels
        Reported Cases


        As of February 22, 2023, the current 7-day average of weekly new cases (33,733) decreased 9.2% compared with the previous 7-day average (37,135). A total of 103,268,408 COVID-19 cases have been reported in the United States as of February 22, 2023.

        103,268,408
        Total Cases Reported

        33,733
        Current 7-Day Average*

        37,135
        Previous 7-Day Average

        -9.2%
        Change in 7-Day Average since Previous Period

        *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 57,680 historical cases reported retroactively, 31,776 were reported in the current week and none in the prior week.

        Weekly Trends in COVID-19 Cases in the United States Reported to CDC


        View Larger
        More Case DataCOVID-19 Variants


        CDC Nowcast projections* for the week ending February 25, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, BQ.1.1, BQ.1, and XBB.

        XBB.1.5 is projected to be at approximately 85.0% (95% PI 79.8-89.1%). BQ.1.1, BQ.1, and XBB are all projected to be between 1% and 9.4% of circulating lineages.

        XBB.1.5 is growing in proportion in all HHS regions. All other virus lineages are predicted to have very slow or no growth in proportion.

        See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

        *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.


        View Larger
        Vaccinations


        As of February 22, 2023, 671.6 million vaccine doses have been administered in the United States. Overall, about 230.0 million people, or 69.3% of the total U.S. population, have completed a primary series.* About 53.4 million people, or 16.1% of the U.S. population , have received an updated booster dose.

        671,582,379
        Vaccine Doses Administered

        53,758,743
        Updated Booster Doses Administered**

        229,996,296
        People who have completed a primary series* (69.3% of the U.S. population)

        53,350,658
        People who have received an updated booster (16.1% of the eligible U.S. population)

        +0.1
        Percentage point change from last week

        +0.1
        Percentage point change from last week

        *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

        **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

        Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

        7-Day moving average


        View Larger
        COVID-19 Updated Booster Dose Administration, United States


        View Larger
        More Vaccination Data
        Hospitalizations

        New Hospital Admissions


        The current 7-day daily average for February 15–21, 2023, was 3,504. This is a 4.9% decrease from the prior 7-day average (3,686) from February 8–14, 2023.

        5,975,373
        Total New Admissions

        3,504
        Current 7-Day Average

        3,686
        Prior 7-Day Average

        -4.9%
        Change in 7-Day Average

        The start of consistent reporting of hospital admissions data was August 1, 2020.

        Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


        View Larger
        New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

        More Hospital Data
        RESP-NET: COVID-19 Associated Hospitalization Rates among Adults and Children (All Ages)


        CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) shows that overall weekly rates of COVID-19-associated hospitalizations continue to decline. The rates for the 2022-2023 season have declined to 6.2 per 100,000 population for the week ending February 4, 2023, a decrease of nearly 50% from an earlier peak in December 2022.

        Overall Weekly Rates of Respiratory Virus-Associated Hospitalizations Among Adults and Children


        View Larger


        The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

        More COVID-NET Data
        Deaths


        The current 7-day average of new deaths (344) decreased 15.2% compared with the previous 7-day average (405). As of February 22, 2023, a total of 1,115,637 COVID-19 deaths have been reported in the United States.

        1,115,637
        Total Deaths Reported

        344
        Current 7-Day Average*

        405
        Prior 7-Day Average

        -15.2%
        Change in 7-Day Average Since Prior Period

        *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 4,113 historical deaths reported retroactively, none were reported in the current week and 62 were reported in the prior week.

        Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


        View Larger
        More Death Data
        Testing


        The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is decreasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 9.8%. The 7-day average number of tests reported for February 10–16, 2023, was 236,244, down 13.8% from 274,144 for the prior 7 days.

        1,018,422,204
        Total Tests Reported

        236,244
        7-Day Average Tests Reported

        9.8%
        7-Day Average % Positivity

        9.9%
        Previous 7-Day Average % Positivity

        -0.07
        Percentage point change in 7-Day Average % Positivity since Prior Week

        *Test for SARS-CoV-2, the virus that causes COVID-19

        COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


        View Larger
        More Testing DataWastewater Surveillance


        COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,200 testing sites across the country.

        Currently, about 67% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 30% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 43% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 45% are reporting an increase.

        For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

        *The virus that causes COVID-19

        SARS-CoV-2 Levels in Wastewater by Site


        View Larger


        0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

        More Wastewater Data

        https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

        Comment


        • #79


          Print
          Subscribe to the Weekly Review

          Interpretive Summary for March 3, 2023
          Streamlining COVID-19 Vaccine Recommendations


          On February 24, 2023, CDC’s Advisory Committee on Immunization Practices (ACIP) met to discuss the latest COVID-19 vaccine data, as well as potential updates to future COVID-19 vaccination efforts. The discussion included an update on vaccine safety, a risk-benefit assessment of the updated COVID-19 vaccines, and anticipated vaccine updates later this year.

          CDC presented new data showing that the updated vaccines protect people against current variants, and the committee expressed support for streamlining and simplifying COVID-19 vaccine recommendations this fall. This includes phasing out the original (monovalent) vaccines and replacing them with the updated (bivalent) vaccines, which protect against the original COVID-19 strain and more recent Omicron subvariants. This change would affect only the people who have not yet received their primary vaccination series, and the U.S. Food & Drug Administration must authorize it before CDC can make a recommendation.

          At this point in the pandemic, COVID-19 cases, hospitalizations, and deaths have been decreasing for several weeks, and much of the country has protection against circulating strains either through vaccination, previous infection, or a combination of both. But it’s important to remember that new subvariants continue to emerge—and even if you had COVID-19 before, reinfection is possible and can cause serious illness. We also know that protection from infection-related immunity wanes over time, just like it does from vaccination.

          CDC encourages the millions of people in the United States who haven’t gotten a COVID-19 vaccine since the fall, when the updated vaccines were released, to do so now to better protect themselves from severe illness and death. This is particularly true for older adults (50+), people who are immunocompromised or have weakened immune systems, and people with underlying conditions who are at higher risk. Individual situations and COVID-19 vaccine options may be confusing to some. Talk with your healthcare provider for specific information about COVID-19 vaccination related to your situation. Find a vaccine.

          Note to Readers: The Disability Information and Access Line can help people with disabilities find local vaccination locations, make appointments, find accessible transportation options, and connect with other community resources to improve access to vaccinations.

          Note to Readers: COVID Data Tracker Weekly Review will publish every other week starting March 3. Please visit CDC’s COVID Data Tracker for COVID-19 data, CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for data on respiratory virus-associated hospitalizations, and CDC’s National Emergency Department Visits for COVID-19, Influenza, and Respiratory Syncytial Virus dashboard for data on emergency department patient visits with diagnosed COVID-19, influenza, and RSV.

          COVID-19 Community Levels*


          As of March 2, 2023, there are 77 (2.4%) counties, districts, or territories with a high COVID-19 Community Level, 514 (16.0%) with a medium Community Level, and 2,628 (81.6%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level increased by 0.3%, in the medium level decreased by 4.4%, and in the low level increased by 4.0%. Overall, 45 out of 52 jurisdictions** had high- or medium-level counties this week. Delaware, District of Columbia, Hawaii, Maryland, New Hampshire, Rhode Island, and Utah are the only jurisdictions to have all counties at low Community Levels.

          To check your COVID-19 Community Level, visit COVID Data Tracker. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

          *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

          **Includes the 50 states, the District of Columbia, and Puerto Rico.

          U.S. COVID-19 Community Levels by County


          View Larger
          COVID-19 Community Levels
          Reported Cases


          As of March 1, 2023, the current 7-day average of weekly new cases (32,374) decreased 5.1% compared with the previous 7-day average (34,102). A total of 103,499,382 COVID-19 cases have been reported in the United States as of March 1, 2023.

          103,499,382
          Total Cases Reported

          32,374
          Current 7-Day Average*

          34,102
          Previous 7-Day Average

          -5.1%
          Change in 7-Day Average since Previous Period

          *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 55,875 historical cases reported retroactively, none were reported in the current week and 29,971 in the prior week.

          Weekly Trends in COVID-19 Cases in the United States Reported to CDC


          View Larger
          More Case DataCOVID-19 Variants


          CDC Nowcast projections* for the week ending March 4, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, BQ.1.1, and BQ.1.

          XBB.1.5 is projected to be at approximately 89.6% (95% PI 85.6-92.6%).

          BQ.1.1 and BQ.1 are projected to be between 1% and 6.7% of circulating lineages.

          XBB.1.5 is growing in proportion in all HHS regions. All other virus lineages are predicted to have very slow or no growth in proportion.

          See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

          *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.


          View Larger
          Vaccinations


          As of March 1, 2023, 672.1 million vaccine doses have been administered in the United States. Overall, about 230.1 million people, or 69.3% of the total U.S. population, have completed a primary series.* About 53.7 million people, or 16.2% of the U.S. population, have received an updated booster dose.

          672,076,105
          Vaccine Doses Administered

          54,086,801
          Updated Booster Doses Administered**

          230,075,934
          People who have completed a primary series* (69.3% of the U.S. population)

          53,663,902
          People who have received an updated booster (16.2% of the eligible U.S. population)

          +0.0
          Percentage point change from last week

          +0.1
          Percentage point change from last week

          *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

          **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

          Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

          7-Day moving average


          View Larger
          COVID-19 Updated Booster Dose Administration, United States


          View Larger
          More Vaccination Data
          Hospitalizations

          New Hospital Admissions


          The current 7-day daily average for February 22–28, 2023, was 3,318. This is a 7.9% decrease from the prior 7-day average (3,604) from February 15–21, 2023.

          5,999,572
          Total New Admissions

          3,318
          Current 7-Day Average

          3,604
          Prior 7-Day Average

          -7.9%
          Change in 7-Day Average

          The start of consistent reporting of hospital admissions data was August 1, 2020.

          Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


          View Larger
          New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

          More Hospital Data
          RESP-NET: COVID-19 Trends in Hospitalizations Among Adults Ages 65 Years and Older


          CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) shows that overall weekly rates of COVID-19-associated hospitalizations among adults ages 65 years and older remain elevated, at 26.1 per 100,000 population for the week ending February 11, 2023.

          Weekly Rates of Respiratory Virus-Associated Hospitalizations Among Adults 65 Years and Older


          View Larger


          The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

          More COVID-NET Data
          Deaths


          The current 7-day average of new deaths (327) decreased 3.3% compared with the previous 7-day average (338). As of March 1, 2023, a total of 1,117,856 COVID-19 deaths have been reported in the United States.

          1,117,856
          Total Deaths Reported

          327
          Current 7-Day Average*

          338
          Prior 7-Day Average

          -3.3%
          Change in 7-Day Average Since Prior Period

          *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 4,113 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

          Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


          View Larger
          More Death Data
          Testing


          The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is decreasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 8.8%. The 7-day average number of tests reported for February 17–23, 2023, was 209,952, down 21.1% from 266,005 for the prior 7 days.

          1,020,487,677
          Total Tests Reported

          209,952
          7-Day Average Tests Reported

          8.8%
          7-Day Average % Positivity

          9.6%
          Previous 7-Day Average % Positivity

          -0.81
          Percentage point change in 7-Day Average % Positivity since Prior Week

          *Test for SARS-CoV-2, the virus that causes COVID-19

          COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


          View Larger
          More Testing DataWastewater Surveillance


          COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,200 testing sites across the country.

          Currently, about 62% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 27% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 49% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 40% are reporting an increase.

          For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

          *The virus that causes COVID-19

          SARS-CoV-2 Levels in Wastewater by Site


          View Larger


          0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

          More Wastewater Data

          https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

          Comment


          • #80


            Print
            Subscribe to the Weekly Review

            Interpretive Summary for March 17, 2023
            Spring into Action


            As we mark three years of the COVID-19 pandemic, cases, deaths, and hospitalizations have all been decreasing steadily. Much of the U.S. population has some form of immunity, either through vaccination or previous infection. In addition, CDC’s 2023 Child and Adolescent Immunization Schedule now includes COVID-19 primary vaccine series and links to the latest guidance on booster dose vaccination in all populations.

            Recommendations for COVID-19 vaccines for kids can be confusing. The pediatric vaccines and boosters were introduced by age group, and there are slightly different recommendations by manufacturer and for children who are immunocompromised. Children of different ages in the same family might not have the same COVID-19 vaccine schedules. The new guidance will make it easier to figure out if your kids are up to date or when they should get their next shot.

            Regular checkups with a pediatrician provide the opportunity to prevent, screen for, and manage chronic conditions, and to get routine vaccinations for your kids, including COVID-19 vaccines. Your pediatrician can explain guidance and help make sure that your child is up to date with all vaccines. So put “make a pediatrician appointment” on top of your spring to-do list.

            Note to Readers: COVID Data Tracker Weekly Review will publish its final issues on March 31, April 14, and May 12. Please visit CDC’s COVID Data Tracker for COVID-19 data, CDC’s Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for data on respiratory virus-associated hospitalizations, and CDC’s National Emergency Department Visits for COVID-19, Influenza, and Respiratory Syncytial Virus dashboard for data on emergency department patient visits with diagnosed COVID-19, influenza, and RSV.

            COVID-19 Community Levels*


            As of March 16, 2023, there are 49 (1.5%) counties, districts, or territories with a high COVID-19 Community Level, 310 (9.6%) with a medium Community Level, and 2,861 (88.7%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level decreased by 0.4%, in the medium level decreased by 3.4%, and in the low level increased by 3.8%. Overall, 38 out of 52 jurisdictions** had high- or medium-level counties this week. Alabama, Connecticut, Delaware, the District of Columbia, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Hampshire, North Carolina, Oregon, Rhode Island, and South Carolina are the jurisdictions that have all counties at low Community Levels.

            To check your COVID-19 Community Level, visit COVID Data Tracker. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

            *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

            **Includes the 50 states, the District of Columbia, and Puerto Rico.

            U.S. COVID-19 Community Levels by County


            View Larger
            COVID-19 Community Levels
            Reported Cases


            As of March 15, 2023, the current 7-day average of weekly new cases (21,422) decreased 19.7% compared with the previous 7-day average (26,685). A total of 103,801,821 COVID-19 cases have been reported in the United States as of March 15, 2023.

            103,801,821
            Total Cases Reported

            21,422
            Current 7-Day Average*

            26,685
            Previous 7-Day Average

            -19.7%
            Change in 7-Day Average since Previous Period

            *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 56,201 historical cases reported retroactively, 347 were reported in the current week and none in the prior week.

            Weekly Trends in COVID-19 Cases in the United States Reported to CDC


            View Larger
            More Case DataCOVID-19 Variants


            CDC Nowcast projections* for the week ending March 18, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, BQ.1.1, XBB, and XBB.1.5.1.

            XBB.1.5 is projected to be at approximately 90.2% (95% PI 87.4-92.4%).

            BQ.1.1, XBB, and XBB.1.5.1 are projected to be between 2.2% and 3.5% of circulating lineages.

            XBB lineages are the only lineages growing nationally. All other virus lineages are predicted to have very slow or no growth in proportion.

            See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

            *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.


            View Larger
            Vaccinations


            As of March 15, 2023, 673.0 million vaccine doses have been administered in the United States. Overall, about 230.2 million people, or 69.3% of the total U.S. population, have completed a primary series.* About 54.3 million people, or 16.2% of the U.S. population , have received an updated booster dose.

            673,012,265
            Vaccine Doses Administered

            54,750,956
            Updated Booster Doses Administered**

            230,211,943
            People who have completed a primary series* (69.3% of the U.S. population)

            54,295,167
            People who have received an updated booster (16.2% of the eligible U.S. population)

            +0.0
            Percentage point change from last week

            +0.2
            Percentage point change from last week

            *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

            **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

            Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

            7-Day moving average


            View Larger
            COVID-19 Updated Booster Dose Administration, United States


            View Larger
            More Vaccination Data
            Hospitalizations

            New Hospital Admissions


            The current 7-day daily average for March 8–14, 2023, was 2,757. This is a 9.5% decrease from the prior 7-day average (3,046) from March 1–7, 2023.

            6,040,811
            Total New Admissions

            2,757
            Current 7-Day Average

            3,046
            Prior 7-Day Average

            -9.5%
            Change in 7-Day Average

            The start of consistent reporting of hospital admissions data was August 1, 2020.

            Weekly Rates of COVID-19-Associated Hospitalizations Among Infants Ages 6 Months and Younger


            View Larger
            New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

            More Hospital Data
            COVID-NET: Trends in COVID-19 Hospitalizations Among Infants 6 months and Younger


            CDC’s Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET) shows that for the week ending February 25, 2023, the rate of COVID-19-associated hospitalizations for infants ages 6 months and younger, who are not eligible for vaccination, is 12.4 per 100,000 population—the highest of all pediatric groups. These rates have, in general, remained relatively stable from January through early March.

            Weekly Rates of COVID-19-Associated Hospitalizations Among Infants Ages 6 months and Younger


            View Larger
            The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

            More COVID-NET Data
            Deaths


            The current 7-day average of new deaths (244) decreased 18.8% compared with the previous 7-day average (300). As of March 15, 2023, a total of 1,121,512 COVID-19 deaths have been reported in the United States.

            1,121,512
            Total Deaths Reported

            244
            Current 7-Day Average*

            300
            Prior 7-Day Average

            -18.8%
            Change in 7-Day Average Since Prior Period

            *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 4,113 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

            Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


            View Larger
            More Death Data
            Testing


            The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is decreasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 7.2%. The 7-day average number of tests reported for March 3–9, 2023, was 178,921, down 20.8% from 225,960 for the prior 7 days.

            1,023,776,133
            Total Tests Reported

            178,921
            7-Day Average Tests Reported

            7.2%
            7-Day Average % Positivity

            7.7%
            Previous 7-Day Average % Positivity

            -0.43
            Percentage point change in 7-Day Average % Positivity since Prior Week

            *Test for SARS-CoV-2, the virus that causes COVID-19

            COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


            View Larger
            More Testing DataWastewater Surveillance


            COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,400 testing sites across the country.

            Currently, about 53% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 20% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 51% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 38% are reporting an increase.

            For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

            *The virus that causes COVID-19

            SARS-CoV-2 Levels in Wastewater by Site


            View Larger


            0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

            More Wastewater Data

            https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

            Comment


            • #81


              Print
              Subscribe to the Weekly Review

              Interpretive Summary for March 31, 2023
              COVID-19 Data Modernization


              This is part of a series of Weekly Review issues coinciding with the end of the COVID-19 public health emergency and what it means for CDC and the data we report. The first issue published on February 24, 2023, and the final two issues will publish on April 14 and May 12.

              The COVID-19 pandemic fundamentally changed expectations for public health, especially the speed at which credible health information is delivered. It created an opportunity to further transform how we collect, use, and share data at CDC and beyond. That momentum won’t stop when the public health emergency ends on May 11. CDC will continue tracking and reporting COVID-19 data, with some changes, while improving our readiness for the next public health emergency.

              The Data Modernization Initiative (DMI) is our solution to the challenges public health has faced for too long, which have been highlighted during the pandemic. Through the initiative, CDC is creating a world in which data can move faster than disease. Our ultimate goal is to get better, faster, actionable data for decision-making at all levels of public health.

              The pandemic underscored the importance of good data across the nation’s public health system. CDC is working to advance eight core goals [240 KB, 1 page] for public health surveillance of COVID-19:
              • Monitor trends and intensity of SARS-CoV-2 transmission, identify outbreaks, and provide data to initiate case and contact investigations
              • Understand disease severity and the spectrum of illness
              • Monitor and track vaccine distribution, uptake, and effectiveness
              • Describe risk factors for severe disease and transmission
              • Monitor for variants
              • Assess impact on healthcare systems
              • Estimate disease burden, and forecast trends, impact, and clinical and public health needs
              • Monitor impact of disease and interventions on health equity

              DMI’s vision is to create one public health community that can engage robustly with healthcare, communicate meaningfully with the public, improve health equity, and have the means to protect and promote health. The gains we’ve made during the pandemic are now building a bridge to a new kind of surveillance and better approaches to public health data.

              What’s New:
              • The Vaccine Effectiveness page was updated to highlight vaccine effectiveness studies published from October 2022 to February 2023.
              • The new Links to Archived Data and Visualizations page is now live to the public. This new page lists all pages archived from COVID Data Tracker and where the archived information can be found.

              COVID-19 Community Levels*


              As of March 30, 2023, there are 25 (0.8%) counties, districts, or territories with a high COVID-19 Community Level, 279 (8.7%) with a medium Community Level, and 2,915 (90.5%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level decreased by 0.1%, the medium level increased by 2.8%, and in the low level decreased by 2.7%. Overall, 35 out of 52 jurisdictions** had high- or medium-level counties this week. California, Connecticut, Delaware, District of Columbia, Kentucky, Maine, Maryland, Massachusetts, Nevada, New Jersey, North Carolina, Oregon, Puerto Rico, Rhode Island, South Carolina, Utah, and Washington are the jurisdictions that have all counties at low Community Levels.

              To check your COVID-19 Community Level, visit COVID Data Tracker. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

              *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

              **Includes the 50 states, the District of Columbia, and Puerto Rico.

              U.S. COVID-19 Community Levels by County


              View Larger
              COVID-19 Community Levels
              Reported Cases


              As of March 29, 2023, the current 7-day average of weekly new cases (19,999) decreased 9.2% compared with the previous 7-day average (22,035). A total of 104,137,196 COVID-19 cases have been reported in the United States as of March 29, 2023.

              104,137,196
              Total Cases Reported

              19,999
              Current 7-Day Average*

              22,035
              Previous 7-Day Average

              -9.2%
              Change in 7-Day Average since Previous Period

              *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 79,780 historical cases reported retroactively, 5,347 were reported in the current week and 18,232 in the prior week.

              Weekly Trends in COVID-19 Cases in the United States Reported to CDC


              View Larger
              More Case DataCOVID-19 Variants


              CDC Nowcast projections* for the week ending April 1, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, XBB.1.9.1, XBB, XBB.1.5.1, and BQ.1.1.

              XBB.1.5 is projected to be at approximately 87.9% (95% PI 85.0-90.4%).

              XBB.1.9.1, XBB, XBB.1.5.1, and BQ.1.1 are projected to be between 1.9% and 4.6% of circulating lineages.

              XBB.1.5 has reached saturation, and XBB.1.9.1, XBB, and XBB.1.5.1 all have positive growth. All other virus lineages are predicted to have very slow or no growth in proportion.

              See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

              *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.

              Variant Proportions


              View Larger
              Vaccinations


              As of March 29, 2023, 674.0 million vaccine doses have been administered in the United States. Overall, about 230.4 million people, or 69.4% of the total U.S. population, have completed a primary series.* About 54.9 million people, or 16.5% of the U.S. population, have received an updated booster dose.

              674,024,493
              Vaccine Doses Administered

              55,352,840
              Updated Booster Doses Administered**

              230,368,815
              People who have completed a primary series* (69.4% of the U.S. population)

              54,864,032
              People who have received an updated booster (16.5% of the eligible U.S. population)

              +0.1
              Percentage point change from last week

              +0.1
              Percentage point change from last week

              *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

              **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

              Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

              7-Day moving average


              View Larger
              COVID-19 Updated Booster Dose Administration, United States


              View Larger
              More Vaccination Data
              Hospitalizations

              New Hospital Admissions


              The current 7-day daily average for March 22–28, 2023, was 2,370. This is a 5.3% decrease from the prior 7-day average (2,501) from March 15–21, 2023.

              6,074,793
              Total New Admissions

              2,370
              Current 7-Day Average

              2,501
              Prior 7-Day Average

              -5.3%
              Change in 7-Day Average

              The start of consistent reporting of hospital admissions data was August 1, 2020.

              Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


              View Larger
              New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

              More Hospital Data
              COVID-NET: Trends in COVID-19 Hospitalization Rates Among Adults and Children (All Ages)


              CDC’s Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET) shows that overall COVID-19-associated hospitalizations have continued to decline since late December 2022. Hospitalization rates among people of all ages have declined from a peak of 11.6 per 100,000 population for the week ending December 31, 2022, and have remained below 7.0 per 100,000 population since the week ending January 28, 2023.

              Weekly Rates of COVID-19-Associated Hospitalizations Among Adults and Children (All Ages)


              View Larger


              The dashed lines for the current season indicate potential reporting delays and interpretation of trends should exclude data from recent weeks. Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

              More COVID-NET Data
              Deaths


              The current 7-day average of new deaths (228) decreased 29.4% compared with the previous 7-day average (323). As of March 29, 2023, a total of 1,125,366 COVID-19 deaths have been reported in the United States.

              1,125,366
              Total Deaths Reported

              228
              Current 7-Day Average*

              323
              Prior 7-Day Average

              -29.4%
              Change in 7-Day Average Since Prior Period

              *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 4,113 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

              Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


              View Larger
              More Death Data
              Testing


              The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is decreasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 7.1%. The 7-day average number of tests reported for March 17–23, 2023, was 192,093, down 22.0% from 246,346 for the prior 7 days.

              1,027,565,117
              Total Tests Reported

              192,093
              7-Day Average Tests Reported

              7.1%
              7-Day Average % Positivity

              6.5%
              Previous 7-Day Average % Positivity

              +0.56
              Percentage point change in 7-Day Average % Positivity since Prior Week

              *Test for SARS-CoV-2, the virus that causes COVID-19

              COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


              View Larger
              More Testing DataWastewater Surveillance


              COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,400 testing sites across the country.

              Currently, about 43% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 11% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 42% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 51% are reporting an increase.

              For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

              *The virus that causes COVID-19

              SARS-CoV-2 Levels in Wastewater by Site


              View Larger


              0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

              More Wastewater Data

              https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

              Comment


              • #82


                Print
                Subscribe to the Weekly Review

                Interpretive Summary for April 14, 2023
                Moving Forward with COVID-19 Data


                CDC launched COVID Data Tracker in 2020 to provide state and local public health officials and communities with the COVID-19 data they need in one consolidated, easy-to-use location. Over the past three years, COVID Data Tracker has grown to incorporate county, state, national, and global data streams into more than 70 webpages of key pandemic-related information.

                To prepare for the end of the COVID-19 public health emergency [165KB, 2 pages] declaration on May 11, 2023, CDC is transitioning to sustainable national COVID-19 surveillance. CDC will continue to use all available resources to track COVID-19 and monitor its long-term effect on the United States and globally. Variant data is a good example of sustainable surveillance. The virus that causes COVID-19 is constantly changing, with new lineages emerging and then spreading or disappearing. XBB.1.5 became the dominant lineage over the past few months, but it is now starting to wane as other lineages rise. Newer lineages like XBB.1.9.2 and XBB.1.16, both close relatives of XBB.1.5, are starting to rise and could displace XBB.1.5. At this time, the best ways to protect yourself and others from COVID-19 remain the same, regardless of which lineage causes infection. CDC will keep a close watch on these changes and continue to communicate about their potential impact.

                Most data activities on COVID Data Tracker won’t be affected by the end of the public health emergency. In the next and final Weekly Review on May 12, we’ll give a more comprehensive summary of the updates to COVID Data Tracker and where you’ll be able to find the COVID-19 data you need.

                COVID-19 Community Levels*


                As of April 13, 2023, there are 17 (0.5%) counties, districts, or territories with a high COVID-19 Community Level, 79 (2.5%) with a medium Community Level, and 3,117 (96.8%) with a low Community Level. Compared with last week, the number of counties, districts, or territories in the high level increased by 0.1%, in the medium level decreased by 0.9%, and in the low level increased by 0.7%. Overall, 25 out of 52 jurisdictions** had high- or medium-level counties this week.

                To check your COVID-19 Community Level, visit COVID Data Tracker. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention.

                *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. Healthcare facilities use Community Transmission Levels to determine infection control interventions.

                **Includes the 50 states, the District of Columbia, and Puerto Rico.

                U.S. COVID-19 Community Levels by County


                View Larger
                COVID-19 Community Levels
                Reported Cases


                As of April 12, 2023, the current 7-day average of weekly new cases (14,491) decreased 17.3% compared with the previous 7-day average (17,519). A total of 104,348,746 COVID-19 cases have been reported in the United States as of April 12, 2023.

                104,348,746
                Total Cases Reported

                14,491
                Current 7-Day Average*

                17,519
                Previous 7-Day Average

                -17.3%
                Change in 7-Day Average since Previous Period

                *Historical cases are excluded from weekly new cases and 7-day average calculations until they are incorporated into the dataset for the applicable date. Of 79,780 historical cases reported retroactively, none were reported in the current week and none in the prior week.

                Weekly Trends in COVID-19 Cases in the United States Reported to CDC


                View Larger
                More Case DataCOVID-19 Variants


                CDC Nowcast projections* for the week ending April 15, 2023, estimate the proportion of these lineages designated as Omicron with estimates above 1%: XBB.1.5, XBB.1.16, XBB.1.9.1, XBB.1.9.2, XBB.1.5.1, FD.2, and BQ.1.1.

                XBB.1.5 is projected to be at approximately 78.0% (95% PI 73.6-81.8%).

                XBB.1.16, XBB.1.9.1, XBB.1.9.2, XBB.1.5.1, FD.2, and BQ.1.1 are projected to be between 1.0% and 7.2% of circulating lineages.

                XBB.1.16, XBB.1.9.1, XBB.1.9.2, and XBB.1.5.1 all have positive growth. XBB.1.5, FD.2, and BQ.1.1 are all decreasing in proportion. All other virus lineages are predicted to have very slow or no change in proportion.

                See COVID Data Tracker for the proportions of all relevant lineages currently circulating.

                *CDC uses Nowcast projections to predict current variant proportions circulating in the United States. The median time from specimen collection to sequence data reporting is about 3 weeks. As a result, weighted estimates for the most recent few weeks may be unstable or unavailable. View Nowcast estimates on CDC’s COVID Data Tracker website on the Variant Proportions page.

                Variant Proportions


                View Larger
                Vaccinations


                As of April 12, 2023, 674.7 million vaccine doses have been administered in the United States. Overall, about 230.5 million people, or 69.4% of the total U.S. population, have completed a primary series.* About 55.6 million people, or 16.7% of the U.S. population, have received an updated booster dose.

                674,711,945
                Vaccine Doses Administered

                55,818,024
                Updated Booster Doses Administered**

                230,467,642
                People who have completed a primary series* (69.4% of the U.S. population)

                55,577,285
                People who have received an updated booster (16.5% of the eligible U.S. population)

                +0
                Percentage point change from last week

                +0
                Percentage point change from last week

                *Represents the number of people who have received the second dose in a two-dose COVID-19 vaccine series (such as the Pfizer-BioNTech, Moderna, or Novavax vaccines) or one dose of the single-shot Johnson & Johnson’s Janssen vaccine.

                **The number of updated booster doses administered is larger than the number of people who have received an updated booster because one person may receive more than one booster dose.

                Daily Change in the Total Number of Administered COVID-19 Vaccine Doses Reported to CDC by the Date of Administration, United States

                7-Day moving average


                View Larger
                COVID-19 Updated Booster Dose Administration, United States


                View Larger
                More Vaccination Data
                Hospitalizations

                New Hospital Admissions


                The current 7-day daily average for April 4–11, 2023, was 1,870. This is a 14.6% decrease from the prior 7-day average (2,191) from March 29-April 4, 2023.

                6,103,743
                Total New Admissions

                1,870
                Current 7-Day Average

                2,191
                Prior 7-Day Average

                -14.6%
                Change in 7-Day Average

                The start of consistent reporting of hospital admissions data was August 1, 2020.

                Daily Trends in Number of New COVID-19 Hospital Admissions in the United States


                View Larger
                New admissions are pulled from a 10 am EDT snapshot of the HHS Unified Hospital Data – Analytic Dataset. Due to potential reporting delays, data from the most recent 7 days, as noted in the figure above with the grey bar, should be interpreted with caution. Small shifts in historic data may also occur due to changes in the Centers for Medicare & Medicaid Services (CMS) Provider of Services file, which is used to identify the cohort of included hospitals.

                More Hospital Data
                COVID-NET: Trends in COVID-19 Hospitalization Rates Among Adults ages 65 Years and Older


                CDC’s Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET) shows that since the start of the COVID-19 pandemic, people ages 65 years and older have had the highest rates of hospitalization among all adults. While rates remain highest in this age group, they have generally continued to decrease since late December 2022. Preliminary data show a rate of 16.6 per 100,000 population for the week ending March 25, 2023.

                Weekly Rates of COVID-19-Associated Hospitalizations Among Adults and Children (All Ages)


                View Larger
                The Coronavirus Disease 2019 (COVID-19)-Associate­­d Hospitalization Surveillance Network (COVID-NET), a RESP-NET platform, is an additional source for hospitalization data collected through a network of more than 250 acute-care hospitals in 13 states (representing ~10% of the U.S. population). Detailed data on patient demographics, including race and ethnicity, underlying medical conditions, medical interventions, and clinical outcomes, are collected using a standardized case reporting form.

                More COVID-NET Data
                Deaths


                The current 7-day average of new deaths (190) decreased 25.4% compared with the previous 7-day average (254). As of April 12, 2023, a total of 1,128,404 COVID-19 deaths have been reported in the United States.

                1,128,404
                Total Deaths Reported

                190
                Current 7-Day Average*

                254
                Prior 7-Day Average

                -25.4%
                Change in 7-Day Average Since Prior Period

                *Historical deaths are excluded from the weekly new deaths and 7-day average calculations until they are incorporated into the dataset by their applicable date. Of 4,113 historical deaths reported retroactively, none were reported in the current week and none were reported in the prior week.

                Weekly Trends in Number of COVID-19 Deaths in the United States Reported to CDC


                View Larger
                More Death Data
                Testing


                The percentage of COVID-19 NAATs (nucleic acid amplification tests)* that are positive is decreasing in comparison to the previous week. The 7-day average of percent positivity from NAATs is now 6.2%. The 7-day average number of tests reported for March 31–April 6, 2023, was 173,079, down 15.9% from 205,834 for the prior 7 days.

                1,030,796,107
                Total Tests Reported

                173,079
                7-Day Average Tests Reported

                6.2%
                7-Day Average % Positivity

                6.5%
                Previous 7-Day Average % Positivity

                +0.23
                Percentage point change in 7-Day Average % Positivity since Prior Week

                *Test for SARS-CoV-2, the virus that causes COVID-19

                COVID-19 NAAT Laboratory Test 7-day Percent Positivity by State/Territory


                View Larger
                More Testing DataWastewater Surveillance


                COVID Data Tracker’s Wastewater Surveillance tab tracks levels, changes, and detections of SARS-CoV-2* viral RNA in wastewater at over 1,400 testing sites across the country.

                Currently, about 33% of sites across the country are reporting moderate to high SARS-CoV-2 levels in wastewater. About 8% of sites reporting wastewater data are currently seeing some of the highest levels for those sites since December 1, 2021. About 54% of sites are experiencing a decrease in SARS-CoV-2 levels, and about 39% are reporting an increase.

                For more information on how to use wastewater data, visit CDC’s wastewater surveillance website.

                *The virus that causes COVID-19

                SARS-CoV-2 Levels in Wastewater by Site


                View Larger


                0% denotes that levels are the lowest they have been at the site; 100% denotes that levels are the highest they have been at the site.

                Comment


                • #83

                  Covid Tracker Weekly Review
                  Print
                  Interpretive Summary for May 12, 2023 Weekly Review, Signing Off

                  Intro - 05-12-2023
                  This is the 97th and final issue of the COVID Data Tracker Weekly Review.

                  Yesterday, May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of reporting frequency, data sources, or availability.

                  The latest updates to CDC’s COVID Data Tracker reflect these changes. The homepage has a new look, and there are also new landing pages for hospitalizations, emergency department (ED) visits, and death data, as well as visualizations of trends and maps. Several pages have also been retired, but COVID Data Tracker has a page with links to archived data and visualizations.

                  These are the most notable changes to COVID Data Tracker:
                  • Hospital admission rates and the percentage of COVID-19 deaths among all deaths are now the primary surveillance metrics.
                  • COVID-19 hospital admission levels replace COVID-19 Community Levels (CCLs) as the main indicator of county trends. COVID-19 hospital admission levels are comparable with CCLs.
                  • Provisional death certificate data from the National Vital Statistics System (NVSS) will become the primary source for mortality surveillance, replacing aggregate death counts.
                  • Aggregate case and death count reporting has been discontinued.
                  • ED visit data will serve as an early indicator of COVID-19 activity.
                  • County-level COVID-19 Electronic Laboratory Reporting data on test positivity will no longer be posted because national reporting of negative laboratory results is no longer required.
                  • The National Respiratory and Enteric Virus Surveillance System (NREVSS), a voluntary reporting network of more than 450 laboratories, will be the new primary source for regional test positivity data and another early indicator.

                  Please see two new MMWR reports published May 5, 2023—COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration and Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators—for more details about the changes.

                  The United States has mobilized and sustained a historic response to the COVID-19 pandemic. The past three years have been highly challenging in many ways, but together we have made significant progress to reduce the impact COVID-19 has on the health of people and our communities.

                  CDC will continue to report and monitor valuable data, like genomic surveillance; wastewater surveillance; vaccination coverage, safety, and effectiveness; and hospital-related outcomes, from sentinel surveillance platforms like COVID-NET. These data will help inform individual and community public health actions to protect those at highest risk of severe COVID-19, such as older adults and people with underlying conditions. People with weakened immune systems should consider taking additional prevention measures, developing a COVID-19 Personal Plan to protect themselves from severe COVID-19, and speaking to their healthcare providers about early antiviral treatment options to prevent severe disease, hospitalization, and death. And everyone, high-risk or not, should stay up to date with COVID-19 vaccines.

                  In the future, CDC will move toward integrating COVID-19 monitoring within a sustainable respiratory viruses surveillance strategy. CDC displays data for diagnosed or laboratory-confirmed COVID-19, flu, and respiratory syncytial virus (RSV) on the National Syndromic Surveillance Program dashboard (for ED visits) and the RESP-NET dashboard (hospitalizations).

                  For more information: Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap

                  What’s New:
                  Top of Page
                  Last Updated May 12, 2023​


                  Comment


                  • #84



                    Maps, charts, and data provided by CDC, updates Mondays and Thursdays by 8 p.m. ET​


                    United States
                    At a Glance

                    Total Hospitalizations
                    6,196,466
                    Trend in Hospital Admissions

                    -5.9% in past week


                    Total Deaths
                    1,134,300
                    Trend in % COVID-19 Deaths

                    -9.1% in past week


                    Vaccinations
                    Total Updated (Bivalent) Vaccine
                    Doses Distributed
                    139,918,910


                    CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

                    Comment


                    • #85


                      United States
                      At a Glance

                      Total Hospitalizations
                      6,202,800
                      Trend in Hospital Admissions

                      -0.8% in past week


                      Total Deaths
                      1,134,300
                      Trend in % COVID-19 Deaths

                      -9.1% in past week


                      Vaccinations
                      Total Updated (Bivalent) Vaccine
                      Doses Distributed
                      139,918,910​

                      CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

                      Comment


                      • #86


                        United States
                        At a Glance

                        Total Hospitalizations
                        6,209,122
                        Trend in Hospital Admissions

                        -0.9% in past week


                        Total Deaths
                        1,134,710
                        Trend in % COVID-19 Deaths

                        -20% in past week


                        Vaccinations
                        Total Updated (Bivalent) Vaccine
                        Doses Distributed
                        144,182,870​


                        CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.


                        Comment


                        • #87


                          Total Hospitalizations
                          6,216,701

                          Trend in Hospital Admissions

                          +10.3% in most recent week


                          Total Deaths
                          1,135,364

                          Trend in % COVID-19 Deaths

                          No change in most recent week


                          Vaccinations
                          Total Updated (Bivalent) Vaccine
                          Doses Distributed
                          144,182,870


                          CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

                          Comment


                          • #88


                            United States
                            At a Glance

                            Total Hospitalizations
                            6,224,831
                            Trend in Hospital Admissions

                            +12.1% in most recent week


                            Total Deaths
                            1,135,919
                            Trend in % COVID-19 Deaths

                            No change in most recent week


                            Vaccinations
                            Total Updated (Bivalent) Vaccine
                            Doses Distributed
                            144,182,870​

                            CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

                            Comment


                            • #89


                              United States
                              At a Glance

                              Total Hospitalizations
                              6,233,900
                              Trend in Hospital Admissions

                              +12.5% in most recent week


                              Total Deaths
                              1,136,473
                              Trend in % COVID-19 Deaths

                              No change in most recent week


                              Vaccinations
                              Total Updated (Bivalent) Vaccine
                              Doses Distributed
                              144,182,870​

                              CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

                              Comment


                              • #90
                                bump this

                                Comment

                                Working...
                                X